NAUT - NASDAQ

Nautilus Biotechnology, Inc.

NAUT·NASDAQ

$2.71

+0.93%

HealthcareBiotechnology

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$343.75M

EPS-0.4700

P/E Ratio-5.76

Earnings Date08/04/2026

naut

Total Equity

Last Annual Value

156.97M

3-Year CAGR

-21%

5-Year CAGR

49%

10-Year CAGR

41%

Adjust for Inflation

Nautilus Biotechnology, Inc. Competitors Analysis of Total Equity

NAUT · NASDAQ

Company	Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
Nautilus Biotechnology, Inc. NASDAQ:NAUT	156.97M	-16.1%	-15.5%	N/A
Tenaya Therapeutics, Inc. NASDAQ:TNYA	123.27M	-4.0%	-15.0%	N/A
Zura Bio Limited NASDAQ:ZURA	101.54M	8.5%	-4.9%	N/A
Humacyte, Inc. NASDAQ:HUMA	3.11M	-38.8%	-52.0%	N/A
Arcturus Therapeutics Holdings Inc. NASDAQ:ARCT	213.99M	-8.4%	-1.3%	16.3%
Sagimet Biosciences Inc. NASDAQ:SGMT	111.38M	6.9%	N/A	N/A
Immuneering Corporation NASDAQ:IMRX	218.48M	34.1%	7.0%	N/A
Agenus Inc. NASDAQ:AGEN	-277.86M	N/A	N/A	N/A
Cognition Therapeutics, Inc. NASDAQ:CGTX	34.27M	11.9%	-7.7%	N/A
Context Therapeutics Inc. NASDAQ:CNTX	60.47M	72.1%	4.6%	N/A
TuHURA Biosciences, Inc. NASDAQ:HURA	20.93M	N/A	N/A	12.3%

Nautilus Biotechnology, Inc. Fair Value Envelope

NAUT · NASDAQ

Our analysis suggests that NAUT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.705, this represents a potential HIDDEN relative to our calculated worth for Nautilus Biotechnology, Inc..

HIDDEN

Intrinsic Value

Current Price: $2.705

Related Guides

Blog Categories

Continue your NAUT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.